Longwe, Herbert, Gordon, Stephen ORCID: https://orcid.org/0000-0001-6576-1116, Malamba, Rose and French, Neil (2010) 'Characterising B cell numbers and memory B cells in HIV infected and uninfected Malawian adults'. BMC Infectious Diseases, Vol 10, p. 280.
|
Text
Characterising_B_Cell_numbers_and_memory_B_cells_in_HIV_infected_and_uinfected_Malawian_adults.pdf - Published Version Available under License Creative Commons Attribution. Download (364kB) |
Abstract
BACKGROUND: Untreated human immunodeficiency virus (HIV) disease disrupts B cell populations causing reduced memory and reduced naïve resting B cells leading to increases in specific co-infections and impaired responses to vaccines. To what extent antiretroviral treatment reverses these changes in an African population is uncertain.
METHODS: A cross-sectional study was performed. We recruited HIV-uninfected and HIV-infected Malawian adults both on and off antiretroviral therapy attending the Queen Elizabeth Central hospital in Malawi. Using flow cytometry, we enumerated B cells and characterized memory B cells and compared these measurements by the different recruitment groups.
RESULTS: Overall 64 participants were recruited - 20 HIV uninfected (HIV-), 30 HIV infected ART naïve (HIV+N) and 14 HIV-infected ART treated (HIV+T). ART treatment had been taken for a median of 33 months (Range 12-60 months). Compared to HIV- the HIV+N adults had low absolute number of naïve resting B cells (111 vs. 180 cells/μl p = 0.008); reduced memory B cells (27 vs. 51 cells/μl p = 0.0008). The HIV+T adults had B-cell numbers similar to HIV- except for memory B cells that remained significantly lower (30 vs. 51 cells/μl p = 0.02). In the HIV+N group we did not find an association between CD4 count and B cell numbers.
CONCLUSIONS: HIV infected Malawian adults have abnormal B-cell numbers. Individuals treated with ART show a return to normal in B-cell numbers but a persistent deficit in the memory subset is noted. This has important implications for long term susceptibility to co-infections and should be evaluated further in a larger cohort study.
Item Type: | Article |
---|---|
Subjects: | QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 268.5 Antiviral agents (General) QW Microbiology and Immunology > Immune Responses > QW 700 Infection. Mechanisms of infection and resistance. WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503 Acquired immunodeficiency syndrome. HIV infections WC Communicable Diseases > Virus Diseases > Acquired Immunodeficiency Syndrome. HIV Infections > WC 503.5 Complications |
Faculty: Department: | Groups (2002 - 2012) > Clinical Group |
Digital Object Identifer (DOI): | https://doi.org/10.1186/1471-2334-10-280 |
Related URLs: | |
Depositing User: | Users 379 not found. |
Date Deposited: | 28 Sep 2012 14:25 |
Last Modified: | 07 Oct 2019 08:23 |
URI: | https://archive.lstmed.ac.uk/id/eprint/3040 |
Statistics
Actions (login required)
Edit Item |